YBGJ

Yubo International Biotech Ltd. operates in the electromedical & electrotherapeutic apparatus industry. listed on OTC. headquartered in BEIJING, F4.

Yubo International Biotech Ltd (YBGJ) is publicly traded on OTC within the Healthcare sector , specifically in the Electromedical & Electrotherapeutic Apparatus industry. The company is headquartered in BEIJING, F4.

Business classification: According to SEC filings, Yubo International Biotech Ltd falls under SIC code 3845 — Electromedical & Electrotherapeutic Apparatus. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating YBGJ should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Electromedical & Electrotherapeutic Apparatus industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare YBGJ with peer companies in Electromedical & Electrotherapeutic Apparatus to assess relative positioning.

Regulatory disclosures: With CIK 0000895464, Yubo International Biotech Ltd files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.